What is the all-time high and low for DaVita stock?
The all-time high DaVita stock closing price was 133.78 on August 04, 2021. The DaVita 52-week high stock price is 136.48, which is 38.1% above the current share price. The DaVita 52-week low stock price is 94.38, which is 4.5% below the current share price.
Where can I buy DaVita shares?
Shares of DVA can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include WeBull, Vanguard Brokerage Services, TD Ameritrade, E*TRADE, Robinhood, Fidelity, and Charles Schwab. Compare Top Brokerages Here. What is DaVita's stock price today?
What is the target price for DaVita Inc?
DVA: Raising target price to $120.00 DAVITA INC has an Investment Rating of HOLD; a target price of $120.000000; an Industry Subrating of High; a Management Subrating of Medium; a Safety Subrating of Medium; a Financial Strength Subrating of Medium; a Growth Subrating of Low; and a Value Subrating of Medium.
What are analysts'target prices for DaVita's shares?
7 analysts have issued 12-month target prices for DaVita's shares. Their forecasts range from $111. 00 to $150. 00. On average, they expect DaVita's share price to reach $132. 50 in the next twelve months. This suggests a possible upside of 14. 7% from the stock's current price.
See more
Is DaVita a good stock to buy?
Valuation metrics show that DaVita Inc. may be undervalued. Its Value Score of A indicates it would be a good pick for value investors. The financial health and growth prospects of DVA, demonstrate its potential to outperform the market.
Does DaVita stock pay dividends?
Does DaVita pay dividends? We have never paid cash dividends and have no current plans to do so in the future.
Is DaVita publicly traded?
The company then changed its name to Total Renal Care Holdings, Inc. In October 1995, the company became a public company via an initial public offering, raising $107 million.
Why is DVA stock down?
DaVita Inc. shares dropped in the extended session Thursday after the dialysis-service provider's earnings fell short of Wall Street estimates as the company said COVID-19 factors and higher wages dinged its bottom line.
Does Davita offer stock options?
The company offers stock discounted purchases once a year. You can opt to do monthly payroll deductions across the year to pay for your purchase. I am SO very excited about this!! can purchase stock at 30% discount.
How do I invest in DaVita?
How to buy shares in DaVita HealthCare PartnersCompare share trading platforms. Use our comparison table to help you find a platform that fits you.Open your brokerage account. ... Confirm your payment details. ... Research the stock. ... Purchase now or later. ... Check in on your investment.
Is DaVita not for profit?
In 2014, DaVita Village Trust, a 501(c)(3) public charity, brought together these two prominent nonprofit organizations and today operates under the brand name of “Bridge of Life,” serving men, women and children through the following programs: kidney care, chronic disease prevention and kids' camps.
Who owns DaVita Healthcare?
Optum, a leading health services company, completed its acquisition of DaVita Medical Group, one of the nation's leading independent medical groups, from DaVita Inc. (NYSE: DVA).
Should I buy or sell DaVita stock right now?
6 Wall Street equities research analysts have issued "buy," "hold," and "sell" ratings for DaVita in the last year. There are currently 5 hold rati...
What is DaVita's stock price forecast for 2022?
6 brokers have issued 1-year price objectives for DaVita's stock. Their forecasts range from $110.00 to $150.00. On average, they predict DaVita's...
How has DaVita's stock price performed in 2022?
DaVita's stock was trading at $113.76 at the start of the year. Since then, DVA shares have decreased by 18.1% and is now trading at $93.16. View...
When is DaVita's next earnings date?
DaVita is scheduled to release its next quarterly earnings announcement on Tuesday, August 2nd 2022. View our earnings forecast for DaVita .
How were DaVita's earnings last quarter?
DaVita Inc. (NYSE:DVA) announced its earnings results on Thursday, May, 5th. The company reported $1.61 earnings per share for the quarter, missing...
What guidance has DaVita issued on next quarter's earnings?
DaVita updated its FY 2022 earnings guidance on Monday, May, 23rd. The company provided EPS guidance of $7.50-$8.50 for the period, compared to the...
Who are DaVita's key executives?
DaVita's management team includes the following people: Mr. Javier J. Rodriguez , CEO & Exec. Director (Age 51, Pay $3.3M) ( LinkedIn Profile )...
What is Javier Rodriguez's approval rating as DaVita's CEO?
289 employees have rated DaVita CEO Javier Rodriguez on Glassdoor.com . Javier Rodriguez has an approval rating of 77% among DaVita's employees.
Who are some of DaVita's key competitors?
Some companies that are related to DaVita include Laboratory Co. of America (LH) , Quest Diagnostics (DGX) , Chemed (CHE) , R1 RCM (RCM) , LHC...
What is a Davita?
Is Davita a hold?
DaVita Inc. provides kidney dialysis services for patients suffering from chronic kidney failure or end stage renal disease (ESRD). The company operates kidney dialysis centers and provides related lab services in outpatient dialysis centers. It also provides outpatient, hospital inpatient, and home-based hemodialysis services; owns clinical laboratories that provide routine laboratory tests for dialysis and other physician-prescribed laboratory tests for ESRD patients; and management and administrative services to outpatient dialysis centers. In addition, the company provides disease management services; vascular access services; clinical research programs; physician services; and comprehensive care services. As of December 31, 2020, it provided dialysis and administrative services in the United States through a network of 2,816 outpatient dialysis centers serving approximately 204,200 patients; and operated 321 outpatient dialysis centers located in 10 countries outside of the United States serving approximately 36,700 patients. Further, the company provides acute inpatient dialysis services in approximately 900 hospitals and related laboratory services in the United States. The company was formerly known as DaVita HealthCare Partners Inc. and changed its name to DaVita Inc. in September 2016. DaVita Inc. was incorporated in 1994 and is headquartered in Denver, Colorado.
Should I hold Davita stock?
Wall Street analysts have given DaVita a "Hold" rating, but there may be better buying opportunities in the stock market. Some of MarketBeat's past winning trading ideas have resulted in 5-15% weekly gains. MarketBeat just released five new stock ideas, but DaVita wasn't one of them.
When will Davita release its ESG report?
The consensus among Wall Street equities research analysts is that investors should "hold" DaVita stock. A hold rating indicates that analysts believe investors should maintain any existing positions they have in DVA, but not buy additional shares or sell existing shares.
How long has healthcare grown earnings per share?
DENVER, April 27, 2021 /PRNewswire/ -- DaVita Inc. today announced its 2025 Environmental, Social and Governance (ESG) goals and released its new ESG reports, bolstering its commitment to corporate citi...
When will Blue Cross and Blue Shield of Minnesota launch in 2021?
The following health care companies have grown their earnings per share over a five-year period. According to the GuruFocus discounted cash flow calculator as of March 31, all of them also trade with a ...
Who is Francis Chou?
EAGAN, Minn., April 12, 2021 /PRNewswire/ -- Blue Cross and Blue Shield of Minnesota (Blue Cross) today announced the launch of an innovative new program with VillageHealth − a DaVita integrated kidney ...
